A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- Or GA-crosslinked collagen scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 2, 2010, Pages 650-658

  Ju, Young Min ^a   Yu, Bazhang ^b   West, Leigh ^b   Moussy, Yvonne ^b   Moussy, Francis ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Collagen; Glutaraldehyde crosslinking; Implantable glucose sensor; NDGA crosslinking; Porous scaffold

Indexed keywords

BIOLOGICAL STABILITY; COLLAGEN SCAFFOLDS; CROSSLINKED; FOREIGN BODY RESPONSE; GLUTARALDEHYDE CROSS-LINKING; GLUTARALDEHYDES; HISTOLOGICAL EXAMINATION; IMPLANTABLE BIOSENSORS; IMPLANTABLE GLUCOSE SENSOR; IN-VITRO; IN-VIVO; MICROMOTION; NDGA CROSSLINKING; NORDIHYDROGUAIARETIC ACID; PHYSICAL STRUCTURES; POROUS SCAFFOLD; SENSITIVITY CHARACTERISTICS; SENSOR FUNCTION;

ALDEHYDES; BIOCOMPATIBILITY; BIOSENSORS; COLLAGEN; ENZYME SENSORS; GENETIC ALGORITHMS; GLUCOSE; GLUCOSE SENSORS; IMPLANTS (SURGICAL); THREE DIMENSIONAL;

SCAFFOLDS;

COLLAGEN TYPE 1; GLUCOSE; GLUTARALDEHYDE; NORDIHYDROGUAIARETIC ACID;

ARTICLE; BIOCOMPATIBILITY; BIOSENSOR; CROSS LINKING; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOSENSING TECHNIQUES; COLLAGEN; CROSS-LINKING REAGENTS; GLUTARAL; MALE; MATERIALS TESTING; NORDIHYDROGUAIARETIC ACID; POROSITY; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE SCAFFOLDS;

EID: 75149116107     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32400     Document Type: Article

References (32)

1. Newman JD, Turner AP. Home blood glucose biosensors: A commercial perspective. Biosens Bioelectron 2005;20:2435-2453.
2. Garg SK, Hoff HK, Chase HP. The role of continuous glucose sensors in diabetes care. Endocrinol Metab Clin North Am 2004;33:163-173, x-xi.
3. Chia CW, Saudek CD. Glucose sensors: Toward closed loop insulin delivery. Endocrinol Metab Clin North Am 2004;33: 175-195, xi.
4. Mercado RC, Moussy F. In vitro and in vivo mineralization of Nafion membrane used for implantable glucose sensors. Biosens Bioelectron 1998;13:133-145.
5. Klueh U, Dorsky DI, Kreutzer DL. Use of vascular endothelial cell growth factor gene transfer to enhance implantable sensor function in vivo. J Biomed Mater Res A 2003;67:1072-1086.
6. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401-412.
7. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res 1998;40:586-597.
8. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 1998;40:598-605.
9. Reichert WM, Saavedra SS. Materials considerations in the selection, performance, and adhesion of polymeric encapsulants for implantable sensors. In: Williams DF, editor. Medical and Dental Materials. New York: VCH Publishers, Inc.; 1992. p 303-343.
10. Reichert WM, Sharkawy AA. Chap. 28: Biosonsors. In: Von Recum A, editor. Handbook of Biomaterials Evaluation: Scientific, Technical, and Clinical Testing of Implant Materials. Philadelphia: Taylor & Francis; 1999. p 439-460.
11. Wisniewski N, Moussy F, Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000;366(6-7):611-621.
12. Pfeiffer EF. On the way to the automated (blood) glucose regulation in diabetes: The dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985. Diabetologia 1987;30: 51-65.
13. Clark LC Jr, Noyes LK, Spokane RB, Sudan R, Miller ML. Long-term implantation of voltammetric oxidase/peroxide glucose sensors in the rat peritoneum. Methods Enzymol 1988;137:68-89.
14. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes 1990;39:1519-1526.
15. Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D. Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. ASAIO J 1994;40:157-163.
16. Gilligan BJ, Shults MC, Rhodes RK, Updike SJ. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994;17:882-887.
17. Pickup JC, Claremont DJ, Shaw GW. Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man. Acta Diabetol 1993;30:143-148.
18. Shichiri M, Yamasaki Y, Nao K, Sekiya M, Ueda N. In vivo characteristics of needle-type glucose sensor-measurements of subcutaneous glucose concentrations in human volunteers. Horm Metab Res Suppl 1988;20:17-20.
19. Ertefai S, Gough DA. Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensors. J Biomed Eng 1989;11:362-368.
20. Moussy F, Jakeway S, Harrison DJ, Rajotte RV. In vitro and in vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing. Anal Chem 1994;66:3882-3888.
21. Moussy F, Harrison DJ, Rajotte RV. A miniaturized Nafion-based glucose sensor: In vitro and in vivo evaluation in dogs. Int J Artif Organs 1994;17:88-94.
22. Quinn CP, Pathak CP, Heller A, Hubbell JA. Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. Biomaterials 1995; 16:389-396.
23. Nishida K, Sakakida M, Ichinose K, Uemura T, Uehara M, Kajiwara K, Miyata T, Shichiri M, Ishihara K, Nakabayashi N. Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate. Med Prog Technol 1995;21:91-103.
24. Quinn CA, Connor RE, Heller A. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials 1997;18:1665-1670.
25. Lei M, Baldi A, Nuxoll E, Siegel RA, Ziaie B. A hydrogel-based implantable micromachined transponder for wireless glucose measurement. Diabetes Technol Ther 2006;8:112-122.
26. Fernandez E, Lopez-Cabarcos E, Mijangos C. Viscoelastic and swelling properties of glucoe oxidase loaded polyacrylamide hydrogels and the evaluation of their properties as glucose sensors. Polymer 2005;46:2211-2217.
27. Gifford R, Batchelor MM, Lee Y, Gokulrangan G, Meyerhoff ME, Wilson GS. Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. J Biomed Mater Res A 2005;75:755-766.
28. Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A 2007;81:858-869.
29. Ju YM, Yu B, Koob TJ, Moussy Y, Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold. J Biomed Mater Res 2008;87:136-146.
30. Dungel P, Long N, Yu B, Moussy Y, Moussy F. Study of the effects of tissue reactions on the function of implanted glucose sensors. J Biomed Mater Res A 2008;85:699-706.
31. Yu B, Ju Y, West L, Moussy Y, Moussy F. An investigation of long-term performance of minimally invasive glucose biosensors. Diabetes Technol Ther 2007;9:265-275.
32. Koob TJ. Biomimetic approaches to tendon repair. Comp Biochem Physiol A: Mol Integr Physiol 2002;133:1171-1192.